Draegerwerk AG & Co KGaA (DRW3) Receives €44.57 Average Price Target from Analysts

Shares of Draegerwerk AG & Co KGaA (ETR:DRW3) have earned a consensus rating of “Hold” from the seven brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and five have issued a hold recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is €44.57 ($51.83).

A number of research analysts have weighed in on the stock. Warburg Research set a €52.00 ($60.47) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Thursday, March 7th. HSBC set a €44.00 ($51.16) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Tuesday, April 16th. Nord/LB set a €45.00 ($52.33) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Friday, March 22nd. Deutsche Bank set a €45.00 ($52.33) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Monday, March 11th. Finally, Hauck & Aufhaeuser set a €42.00 ($48.84) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Monday, March 11th.

ETR DRW3 traded up €0.26 ($0.30) during trading hours on Friday, reaching €49.50 ($57.56). 16,163 shares of the company’s stock were exchanged, compared to its average volume of 33,804. The firm has a market cap of $879.12 million and a PE ratio of 20.00. The company has a debt-to-equity ratio of 20.16, a current ratio of 1.98 and a quick ratio of 1.17. Draegerwerk AG & Co KGaA has a one year low of €42.08 ($48.93) and a one year high of €73.00 ($84.88).

Draegerwerk AG & Co KGaA Company Profile

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Featured Article: Yield Curve

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.